Oxford Nanopore Files for London IPO, with Potential Value of $5.5B

Oxford Nanopore said in its registration filing that it serves customers in more than 100 countries. Researchers are using the Group’s DNA/RNA sequencing technology for purposes that include analyzing human, cancer, plant, microbial/pathogen, food and/or environmental samples. The company‚Äôs tools and technologies have been written up to date in more than 2,100 scientific publications including preprints. Oxford Nanopore said it owns or in-licenses more than 2,000 patents and applications including 800 generated internally across more than 260 patent families.